Table 4.
Frequencies of factors that affect the bone density in patients with psoriasis and osteoporosis, osteopenia, and normal BMD
| Osteoporosis | Osteopenia | Normal BMD | p value | |
|---|---|---|---|---|
| Number (%) | 8 (12.5%) | 28 (43.8%) | 28 (43.8%) | |
| Age | 57.2 ± 20.8 | 47.5 ± 16.1 | 36.5 ± 12.8 | .002 |
| Sex | ||||
| Male | 6 (17.6%) | 17 (50%) | 11 (32.4%) | .114 |
| Female | 2 (6.7%) | 11 (36.7%) | 17 (56.7%) | |
| BMI | 25.1 ± 3.3 | 26.9 ± 3.6 | 27.8 ± 6.2 | .382 |
| Activity | 1 (5.6%) | 10 (55.6%) | 7 (38.9%) | .387 |
| Cigarette smoking | 2 (15.4%) | 7 (53.8%) | 4 (30.8%) | .572 |
| Disease duration | 8 ± 13.2 | 7.7 ± 9.1 | 6.7 ± 4.3 | .859 |
| PASI | 2.9 ± 2.1 | 6.5 ± 4.1 | 5.3 ± 5.5 | .159 |
| Calcium | 9.6 ± 1.4 | 9.9 ± 0.4 | 9.8 ± 0.4 | .537 |
| Phosphorus | 4.6 ± 1.6 | 4.5 ± 0.8 | 4.4 ± 0.8 | .920 |
| Parathyroid Hormone | 41.0 ± 11.0 | 33.1 ± 14.1 | 33.9 ± 19.8 | .671 |
| 25(OH)Vit D3 | 19.8 ± 8.1 | 18.3 ± 13.4 | 15.4 ± 9.7 | .636 |
| ESR | 14.7 ± 4.6 | 16.8 ± 5.4 | 14.7 ± 7.3 | .473 |
| CRP | 2 (25%) | 3 (37.5%) | 3 (37.5%) | .520 |
25(OH)Vit D3, 25-hydroxycholecalciferol and vitamin D3; BMD, bone mineral density; BMI, body mass index; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; PASI, Psoriasis Area and Severity Index.